New Research PaperSystemic Octreotide Therapy in Prevention of Gastrointestinal Bleeds Related to Arteriovenous Malformations and Obscure Etiology in Atrial Fibrillation
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Di Biase is a consultant to Stereotaxis, Biosense Webster, and St. Jude Medical; and has received speaker honoraria/travel reimbursement from Biotronik, Medtronic, Boston Scientific, Janssen, Pfizer, and Epi EP. Dr. Swarup has served as a consultant to Abbot Vascular and Biosense Webster; and is on the speakers bureaus for St. Jude Medical, Boston Scientific, Janssen, and Pfizer. Dr. Gopinathannair has served as a consultant to St. Jude Medical and Boston Scientific; has served on the speakers bureau for the American Heart Association, Pfizer, Bristol-Myers Squibb, Zoll Medical, and AltaThera Pharmaceuticals; and has served on an advisory board for HealthTrust PG. Dr. Natale is a consultant for Stereotaxis, Biosense Webster, and St. Jude Medical; and has received speaker honoraria/travel reimbursements from Biotronik, Medtronic, Boston Scientific, Janssen, Pfizer, and Epi EP. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
All authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Clinical Electrophysiology author instructions page.